Contents of this document
- Launch of sales of “つなぎAI,” a generative AI agent platform
- Launch of “AI Doctor Scheduling,” a medical AI solution
- Research and development of an AI chat platform linked to SharePoint viewing permissions
- Research and development and in-house standardization of AI-driven development
- Launch of a migration development solution
- Strengthening collaboration with Canon IT Solutions Inc.
- Joint research and development in medical AI with Nagasaki University
- Revenue growth5.9 %Year on year against the same period last yearYear on year
- Ordinary income margin10.9 %Year on year against the same period last yearYear on year
- Equity ratio75.8 %
- Cumulative implementations of the expense settlement solution170 companies or more
- End-user transaction ratio65 Over %
- Automated test case automation rate98 %
| Item | Details |
|---|---|
| Document type | Presentation materials for financial results |
| Fiscal Period Covered | Q3 FY2026 |
| Net Sales | ¥7,826 million (YoY +5.9%) |
| Operating profit | ¥842 million (YoY -9.8%) |
| Ordinary income | ¥854 million (YoY -9.5%) |
| Net income | ¥565 million (YoY -10.0%) |
| Gross Profit Margin | 23.3 % |
| Operating profit margin | 10.8 % |
| Selling, general and administrative expenses | ¥984 million |
| Results for the three months of the current quarter | Net Sales ¥2,620 million (YoY +11.3%) / Operating profit ¥234 million (YoY +17.0%) / Ordinary income ¥232 million (YoY +15.4%) |
| Full-year earnings forecast | Net Sales ¥11,000 million / Operating profit ¥1,380 million / Ordinary income ¥1,380 million / Net income ¥920 million |
| Progress against full-year forecast | Net Sales 71.2 % / Operating profit 61.1 % / Ordinary income 61.9 % / Net income 61.5 % |
| Segment results | Business systems development Net Sales ¥5,247 million / yoy_pct ¥6.4 million / IT Infrastructure Net Sales ¥1,140 million / yoy_pct ¥5.8 million / Solutions Net Sales ¥1,438 million / yoy_pct ¥4.5 million |
| Breakdown of Factors Affecting the Change | Increase in revenue ¥439 million / Higher subcontracting expenses ¥-232 million / Increase in other costs ¥-49 million / Increase in recruitment, R&D and other expenses ¥-33 million / Increase in other expenses ¥-31 million / Increase in shareholder benefit expenses ¥-181 million |
| Key KPIs | Indicator name Revenue growth / Value 5.9 % / Year on year against the same period last year Year on year, Indicator name Ordinary income margin / Value 10.9 % / Year on year against the same period last year Year on year, Indicator name Equity ratio / Value 75.8 % / Year on year against the same period last year Not disclosed, Indicator name Cumulative implementations of the expense settlement solution / Value 170 companies or more / Year on year against the same period last year Not disclosed, Indicator name End-user transaction ratio / Value 65 Over % / Year on year against the same period last year Not disclosed, Indicator name Automated test case automation rate / Value 98 % / Year on year against the same period last year Not disclosed |
| Number of employees | Value 597 people (as of the end of September 2025) / Recruitment during the period New graduates 25 People / Career 22 People / Hiring plan The group aims to reach a workforce of 700 people in 2027 |
| Medium-term management plan targets | Target fiscal year Fiscal year ending September 2027 / Net Sales 130 Hundreds of millions of yen / Ordinary income 17 Hundreds of millions of yen / Revenue CAGR 10 % |
| Financial targets | Equity ratio Target 60 % / Actual results 75.8 % / ROE Target 20 % / Actual results Judged based on full-year results / ROIC Target 20 % / Actual results Judged based on full-year results |
| Annual Dividend | ¥14 per share |
| Payout ratio | 57.6 % |
| Acquisition of treasury shares | Past share repurchases are mentioned, but the repurchase limit, number of shares and period for the current fiscal year are not disclosed |
| New initiatives | Launch of sales of “つなぎAI,” a generative AI agent platform, Launch of “AI Doctor Scheduling,” a medical AI solution, Research and development of an AI chat platform linked to SharePoint viewing permissions, Research and development and in-house standardization of AI-driven development, Launch of a migration development solution, Strengthening collaboration with Canon IT Solutions Inc., Joint research and development in medical AI with Nagasaki University |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company attributed the decrease in profit to higher outsourcing costs and cost of sales accompanying revenue growth, upfront investment in recruitment, human-resource development and research and development, increases in other expenses, and differences in the timing of recognizing shareholder benefit expenses. Revenue growth was driven by demand for system development in the public-sector, life insurance and telecommunications fields, municipal DX projects, and the expansion of projects related to AI, cloud-based expense settlement and RPA.